[{"Assets_0_Q3_USD":7177116000.0,"CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q3_USD":-8.68,"EarningsPerShareBasic_3_Q3_USD":40.42,"EarningsPerShareDiluted_1_Q3_USD":-8.68,"EarningsPerShareDiluted_3_Q3_USD":39.97,"Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":298095000.0,"NetIncomeLossConverted_1_Q3_USD":-258816000.0,"NetIncomeLossConverted_3_Q3_USD":1205189000.0,"OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q3_USD":560633000.0,"RevenuesConverted_3_Q3_USD":1687231000.0,"SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q3_USD":5131192000.0,"Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":29831000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":30149000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":29831000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":29815000.0,"filed":"20191101","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2019.0","name":"BIO-RAD LABORATORIES, INC.","period":"20190930","qtrs":"0","uom":"USD"}]